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Objectives. Our main objective was to apply a new method to
determine whether coronary revascularization procedures are
underused, especially among African-Americans and uninsured
patients.
Background. Although overuse of revascularization procedures
has been studied, underuse as defined clinically has not been
examined before.
Methods. The study was conducted at four public and two
academically affiliated private hospitals in Los Angeles; 671
patients who underwent coronary angiography between June 1,
1990 and September 30, 1991 and met explicit clinical criteria for
coronary revascularization were included. The main outcome
measure was the proportion of patients undergoing an indicated
procedure within 12 months (ascertained by medical record
review and confirmed with a telephone survey). Adjusted relative
odds of undergoing an indicated procedure for African-Americans
and patients in public hospitals compared with whites and
patients in private hospitals were calculated.
Results. Overall, 75% of patients underwent a revascularization
procedure. Of 424 patients requiring bypass surgery, 107 angio-
plasty and 140 either bypass surgery or angioplasty, 59%, 66% and
75% underwent the procedure, respectively. African-Americans
were less likely than whites to undergo operation (adjusted odds
ratio [OR] 0.49, p < 0.05) and angioplasty (adjusted OR 0.20, p <
0.05). Patients in public hospitals were less likely than those in
private hospitals to undergo angioplasty (adjusted OR 0.10, p <
0.005).
Conclusions. Underuse of coronary revascularization proce-
dures is measurable and occurs to a significant degree even among
insured patients attending private hospitals. Underuse is espe-
cially pronounced among African-Americans and patients attend-
ing public hospitals. Future cost-containment efforts must incor-
porate safeguards against underuse of necessary care.
(J Am Coll Cardiol 1997;29:891–7)
©1997 by the American College of Cardiology
Variation in the use of medical and surgical procedures has
been documented extensively. Recent studies focusing on
access to cardiac services and use of coronary artery bypass
graft surgery (CABG) and percutaneous transluminal coro-
nary angioplasty (PTCA) have demonstrated that African-
Americans, Latinos and poor and uninsured patients undergo
fewer coronary artery revascularization procedures than white
and insured patients (1–7). The difference in revascularization
rates may be due to either overuse of these procedures among
more privileged patients or underuse among those groups
traditionally considered to have poor access to care.
This study examines possible underuse of coronary revas-
cularization procedures and addresses two main questions: 1)
Are coronary revascularization procedures underused? 2) Are
there groups of patients in whom underuse is more common?
Methods
Definition of underuse and clinical necessity. To measure
underuse, we used the RAND/UCLA set of explicit clinical
criteria for the necessity of coronary revascularization proce-
dures (8–10). These criteria were developed by a nine-member
multispecialty national panel of expert physicians and sur-
geons. Panel members represented internal medicine, invasive
and noninvasive cardiology and cardiothoracic surgery. The
panelists were selected through a national search of nomina-
tions from specialty societies and academic medical centers.
Necessity was defined as follows for the panelists: 1) The
procedure is appropriate (i.e., its benefits to the patient
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outweigh its risks); 2) it would be improper care not to provide
this service to a patient; 3) there is a reasonable chance that
this procedure will benefit the patient (i.e., the probability of
benefit is not small); and 4) the magnitude of the benefit to the
patient is not small (8–10). Panelists rated 2,004 clinically
homogeneous patient scenarios (i.e., indications) first for the
appropriateness and later for necessity of CABG and PTCA
(8–10). The panel process produced 143 necessity indications
for CABG, 36 for PTCA and 69 for any revascularization
(invasive procedure recommended but exact type left to clini-
cal discretion). Table 1 contains examples of necessity indica-
tions for each procedure. The panelists’ ratings were based on
a comprehensive review of the published reports and their
clinical expertise.
Underuse was defined as failure to undergo a necessary
revascularization procedure. Using this definition, underuse
does not necessarily reflect poor quality care because some
patients may have refused procedures that were offered to
them.
Selection of hospitals. The study was conducted at six
teaching hospitals: four public and two large private nonprofit
hospitals in Los Angeles. The study hospitals represented
geographically diverse parts of Los Angeles; all had cardiology
fellowship programs; four had cardiac surgery facilities, and
two did not. The number of beds ranged from 400 to 1,400, and
the number of coronary angiographies performed in 1 year
ranged from 125 to 1,930.
The four public hospitals were selected because, tradition-
ally, public hospitals in California have been the main source of
medical care for the state’s uninsured residents (11,12), and we
wanted to investigate whether underuse of CABG and PTCA
is more prevalent among poor and uninsured patients than
among insured patients in private hospitals. The two private
teaching hospitals were included to represent a practice stan-
dard in hospitals that serve predominantly insured, middle-
class patients.
Sampling of patients and data collection. To determine
whether a procedure was underused, patients with previous
medical need for that procedure must be identified first; then
it can be determined whether they indeed underwent the
necessary procedure. Because all patients who undergo coro-
nary revascularization must first undergo coronary angiogra-
phy, we identified eligible patients from among ;9,100 pa-
tients who had undergone coronary angiography at a study
hospital between January 1, 1990 and September 30, 1991. We
reviewed patient logs kept at each hospital’s cardiac catheter-
ization laboratory and randomly sampled 4,226 cardiac cathe-
terization reports. The 4,226 reports were screened to identify
patients with coronary artery disease. Coronary artery disease
was defined as a 50% left main coronary artery lesion or a 70%
lesion in at least one other coronary artery. At this stage, we
excluded patients without coronary artery disease, patients
with history of CABG or heart transplantation and patients
referred for open heart surgery for reasons other than coro-
nary artery disease. We also excluded patients with single-
vessel coronary artery disease and no symptoms (because such
patients, by definition, did not meet revascularization necessity
criteria). Trained data collectors abstracted the medical
records of the remaining patients to determine whether they
met a necessity indication, and if so, whether they underwent
CABG or PTCA or were offered revascularization but refused.
Data abstracted from medical records included clinical
presentation at the time of the diagnostic catheterization,
intensity of medical therapy (i.e., 0, 1 or .1 type of antianginal
medications), angiographic findings, left ventricular ejection
fraction, presence of other comorbid conditions (e.g., diabetes,
hypertension, kidney failure), results of noninvasive diagnostic
tests for cardiac ischemia, patient age, gender, ethnicity and
performance of a revascularization procedure or evidence that
the patient refused revascularization. Surgical risk was calcu-
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CI 5 confidence interval
OR 5 odds ratio
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Examples of Necessary Indications for Bypass Surgery,
Coronary Angioplasty and Bypass Surgery or Coronary Angioplasty
CABG necessary
Patient has CCS class III/IV chronic stable angina, is receiving maximal
medical therapy, with LMCA disease and left ventricular ejection
fraction .35% at low surgical risk
Patient has CCS class I/II chronic stable angina, is receiving maximal
medical therapy, with three-vessel disease and left ventricular ejection
fraction .35%, at low surgical risk
Within 21 days of an acute myocardial infarction, patient is asymptomatic,
with very positive exercise stress test results, three-vessel disease and left
ventricular ejection fraction .35%, at low surgical risk
PTCA necessary
Patient has CCS class III/IV chronic stable angina, is receiving maximal
medical therapy, with single-vessel disease (proximal LAD) and left
ventricular ejection fraction 15% to 35%, at low surgical risk
Patient has CCS class I/II chronic stable angina, is receiving maximal
medical therapy, with single-vessel disease and left ventricular ejection
fraction .35%, at low surgical risk
Within 21 days of an acute myocardial infarction, patient has continuing
pain, two-vessel disease with proximal LAD involvement and left
ventricular ejection fraction .35%, at high surgical risk
CABG or PTCA necessary
Patient has CCS I/II chronic stable angina, is receiving maximal medical
therapy, with two-vessel disease with proximal LAD involvement and left
ventricular ejection fraction .35%, at moderate surgical risk
Unstable angina with symptoms on maximal medical therapy, two-vessel
disease with proximal LAD involvement and left ventricular ejection
fraction .35%, at low surgical risk
Within 21 days of an acute myocardial infarction, patient has continuing
pain, two-vessel disease with proximal LAD involvement and left
ventricular ejection fraction .35%, at moderate surgical risk
CABG 5 coronary artery bypass graft surgery; CCS 5 Canadian Cardiovas-
cular Society; LAD 5 left anterior descending coronary artery; LMCA 5 left
main coronary artery; PTCA 5 percutaneous transluminal coronary angioplasty;
surgical risk 5 defined according to modified Parsonnett Scale.
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lated on the basis of the presence of comorbidities and age,
using the modified Parsonnet Scale (8,9,13). Abstraction forms
were reviewed by physicians to decide whether each case met
a necessity indication. We identified 671 patients who needed
a necessary revascularization procedure. We also reviewed
CABG and PTCA logs at study hospitals to confirm whether
each patient underwent revascularization.
To collect additional demographic information and to
determine whether patients whose medical records did not
indicate that they had undergone revascularization, we at-
tempted to contact by telephone all patients not known to be
dead. Interviews were conducted between 14 and 38 months
after the coronary angiogram. We followed a protocol that
involved using directory assistance and calling nonrespondents
at least 15 times over several weeks.
Confirmation of necessity among candidates for CABG.
Because preliminary analysis demonstrated a high rate of
underuse even at the private hospitals, we performed a more
detailed clinical review of the 108 patients who needed CABG
but received only medical therapy. Two interventional cardi-
ologists reviewed the primary clinical data on the 108 CABG
candidates to decide whether according to their clinical judg-
ment these patients had clinical need for CABG. At least one
cardiologist rated each of the cases as having a clinical need for
CABG; and they agreed about the vast majority of cases
(78%).
Data analysis. The primary outcome of interest was per-
formance of the necessary revascularization procedure. We
gave credit for performance of necessary CABG or PTCA up
to 12 months after coronary angiography. In the bivariate
analysis, we compared the proportion of patients in different
subgroups who underwent clinically necessary revasculariza-
tion procedures; results were considered significant if the 95%
confidence interval for the difference between groups did not
include 0. The independent associations between gender,
ethnicity and hospital system and receipt of necessary CABG
or PTCA were assessed in three separate logistic regression
models evaluating 1) receipt of CABG, given that CABG was
necessary; 2) receipt of PTCA, given that PTCA was necessary;
and 3) receipt of any revascularization, given that revascular-
ization (type unspecified by panel) was necessary. All three
multivariate models evaluated the effect of gender, ethnicity
and hospital system (private vs. public) while controlling for
age, clinical presentation, angiographic findings and ejection
fraction, but the exact specifications differed due to differences
in sample size and distribution of covariates for each of three
groups of patients. For example, the model predicting receipt
of CABG included a dummy variable for left main coronary
artery disease, but this variable was omitted from the model
predicting PTCA because left main disease was not found
among patients meeting criteria for PTCA.
The first model assessed receipt of necessary CABG among
424 patients who met necessity indications for CABG. Inde-
pendent variables in this model included Canadian Cardiovas-
cular Society class III/IV chronic stable angina, unstable
angina, recent myocardial infarction, left main disease, left
ventricular ejection fraction $50%, age 60 to 69 years, age 70
to 79 years, age $80 years, female gender, African-American,
Latino, Asian/other and coronary angiography performed at a
public hospital.
The second model assessed receipt of necessary PTCA
among 107 patients who met necessity indications for PTCA.
The independent variables in this model included unstable
angina, recent myocardial infarction, left ventricular ejection
fraction $50%, age 60 to 69 years, age 70 to 79 years, female
gender, African-American, Latino and coronary angiography
performed at a public hospital.
The third model included 140 patients who met necessity
indications for any revascularization. Receipt of a revascular-
ization procedure was the outcome variable for this logistic
regression model. Independent variables included unstable
angina, recent myocardial infarction, left ventricular ejection
fraction $50%, age 60 to 69 years, age 70 to 79 years, female
gender, African-American, Latino and coronary angiography
performed at a public hospital.
Results
Patient characteristics. The mean age of patients who met
necessity indications for CABG or PTCA was 60 years: 32%
were female, 55% white, 21% Latino and 12% African-
American (Table 2). Of 601 patients not known to be dead, 374
completed a telephone interview (net response rate 62%). At
the time of coronary angiography, ;36% had chronic stable
angina, 40% had unstable angina, and 23% had an acute
myocardial infarction within 21 days of angiography. Two-
thirds of the patients had left main or triple-vessel coronary
artery disease (Table 2). Of the 671 patients, 424 met necessity
indications for CABG, 107 for PTCA and 140 for any revas-
cularization (type unspecified).
Receipt of necessary CABG or PTCA. Unadjusted results.
Overall, 506 patients (75%) underwent either CABG or PTCA
within 1 year; of these, 85% underwent the procedure pre-
ferred by the expert panel, whereas 15% underwent an alter-
native procedure (i.e., PTCA when CABG was indicated or
CABG when PTCA was indicated). Patients needing an un-
specified revascularization procedure (n 5 140) were almost
evenly split between CABG (39%) and PTCA (40%), and 21%
were treated medically (Table 3). After exclusion of 16 patients
who refused operation (10 identified through medical record
review, 6 through the interview), the overall revascularization
receipt rate increased from 75% to 77% (data not in table).
On bivariate analysis, among all three groups of patients, no
significant associations were seen between receipt of necessary
CABG or PTCA and gender, ethnicity or clinical presentation
at the time of angiography (Table 4). Patients with two-vessel
disease were significantly less likely than those with left main
disease to undergo necessary CABG (Table 4). Left ventricular
ejection fraction ,50% was significantly associated with re-
ceipt of an invasive procedure among patients needing any
revascularization (type unspecified). Patients who underwent
coronary angiography at a public hospital were less likely than
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those treated at a private hospital to undergo necessary PTCA
(p , 0.05) (Table 4). Rates of receipt of necessary CABG were
similar at private and public hospitals (60% vs. 58%) (Table 4).
Adjusted results. Controlling for clinical covariates using
logistic regression, we found that left main disease was strongly
associated with receipt of necessary CABG (adjusted odds
ratio [OR] 3.84, 95% confidence interval [CI], 2.13 to 6.92, p ,
0.0001) (Table 5). No differences were observed between men
and women or between patients who underwent coronary
angiography at a private or public hospital. However, African-
Americans were less likely than whites to undergo necessary
CABG (adjusted OR 0.49, 95% CI, 0.23 to 0.99, p , 0.05).
With respect to PTCA, we found that clinical presentation
with unstable angina or a recent myocardial infarction and
ejection fraction $50% were strongly associated with receipt
of necessary PTCA (Table 5). Patients 70 to 79 years old were
less likely than those ,60 years old to undergo necessary
PTCA. No differences were found between men and women.
African-American patients were less likely than whites to
undergo necessary PTCA (adjusted OR 0.20, 95% CI 0.06 to
0.72, p , 0.05). Patients who underwent coronary angiography
at a public hospital were less likely than those at private
hospitals to undergo necessary PTCA (adjusted OR 0.10, 95%
CI 0.02 to 0.44, p , 0.005).
In the logistic regression model examining the effects of
patient gender, ethnicity and hospital system on receipt of
CABG or PTCA among patients who met necessity indications
for any revascularization, no statistically significant differences
were seen, except that patients with a left ventricular ejection
fraction $50% were significantly more likely to undergo a
necessary procedure than those with impaired left ventricular
function.
Discussion
Although methods to assess the appropriateness of care
have been used to identify and measure overuse of coronary
artery revascularization, to our knowledge, the present study is
the first to demonstrate that these methods can be used to
measure underuse of this costly but potentially beneficial pair
of procedures. In our study of 671 patients who met explicit
indications for the necessity of coronary artery revasculariza-
tion, approximately one-fourth were treated medically, and
more than one-third either did not undergo a revascularization
procedure or underwent one that was presumably suboptimal.
The validity of the results depends on the soundness and
applicability of the 248 necessity indications and the integrity
of the process used to develop them. As described elsewhere
(8–10), the indications are the product of the careful deliber-
ations of nine experts, guided by a comprehensive review of
published reports. They were judged reasonable by cardiolo-
gists at each of the six participating hospitals, and external
evidence for their validity was demonstrated in a related study
that concluded that failure to undergo necessary revasculariza-
tion was correlated with an excess risk of death (14).
Although the overuse of CABG (15,16) and PTCA (17) has
been demonstrated in previous studies, our finding that nec-
essary revascularization procedures are not always provided
Table 3. Receipt of Bypass Surgery or Coronary Angioplasty by
Type of Necessary Procedure
Procedure
Necessary
No. of
Pts
Underwent
CABG
(%)
Underwent
PTCA
(%)
Did Not Undergo
CABG or PTCA
(%)
CABG 424 59 16 25
PTCA 107 8 66 26
CABG or PTCA 140 39 40 21
Total 671 46 29 25
Data presented are number or percent of patients. Pts 5 patients; other
abbreviations as in Table 1.
Table 2. Patient Characteristics According to Type of Procedure
Deemed Necessary
CABG
(n 5 424)
(%)
PTCA
(n 5 107)
(%)
Generic
Revascularization
(n 5 140)
(%)
Clinical presentation
CCS class I/II chronic stable angina 23 13 4
CCS class III/IV chronic stable
angina
18 14 24
Unstable angina* 32 44 59
Post-MI† 26 29 12
Ejection fraction
$50% 49 65 54
,50% 51 35 46
Angiographic findings
LMCA 22 0 0
3-vessel disease 74 0 26
2-vessel disease 3 1 73
1-vessel disease 0 99 1
Age (yr)
,60 44 56 47
60–69 40 38 30
70–79 12 5 22
$80 4 1 1
Gender
Male 71 56 67
Female 29 44 33
Ethnicity
White 56 54 52
African-American 10 10 17
Latino 20 27 19
Asian/other 14 10 11
Angiography hospital
Private 1 13 14 24
Private 2 19 14 16
Public 1 3 5 6
Public 2 20 24 18
Public 3 25 26 16
Public 4 20 17 21
*At the time of coronary angiography. †Within 21 days of an acute
myocardial infarction. Data presented are percent of patients. MI 5 myocardial
infarction; other abbreviations as in Table 1.
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means that clinically meaningful underuse and overuse of the
same procedure may occur simultaneously. Underuse of revas-
cularization procedures was not confined to the poor and
uninsured. Clinically significant underuse was observed among
insured patients at the two private hospitals. This finding
suggests that elimination of financial barriers to care will not
avert underuse of CABG and PTCA without attention to
factors influencing clinical decision making and physician–
patient communication.
The provision of necessary revascularization procedures
was strongly driven by clinical factors. As expected, clinical
severity of illness was the most important influence on whether
revascularization was performed. For example, left main cor-
onary artery disease was the strongest factor associated with
receipt of necessary CABG. Similarly, clinical presentation
with an acute syndrome (unstable angina or chest pain after an
acute myocardial infarction) was strongly associated with re-
ceipt of necessary PTCA.
Nevertheless, nonclinical factors were also associated with
underuse of CABG and PTCA. Patients in public hospitals
were less likely to undergo PTCA (but not CABG) than those
in private hospitals. African-Americans were less likely than
whites to undergo both necessary CABG and PTCA. This
latter finding not only corroborates results of previous studies
(1,2,4,5,7) but shows that CABG and PTCA are underused
among African-Americans relative to whites even after con-
trolling for important clinical factors, including objective ana-
tomic data. Refusal of recommended procedures, at least as
documented in the medical record or reported by telephone
survey responders, did not account for the racial disparities.
Table 4. Unadjusted Associations Between Patient Clinical and Demographic Characteristics and
Hospital Where Coronary Angiography Was Performed With Receipt of Necessary Procedure*
CABG Necessary/
Received CABG
[no. (%)]
PTCA Necessary/
Received PTCA
[no. (%)]
Generic Revascularization
Necessary/Received
CABG or PTCA
[no. (%)]
Clinical presentation
CCS class I/II chronic stable angina 56/98 (57.17) 7/14 (50.0) 5/6 (83.3)
CCS class III/IV chronic stable angina 42/77 (54.6) 7/15 (46.7) 25/34 (73.5)
Unstable angina† 82/137 (59.9) 34/47 (72.3) 69/83 (83.1)
Post-MI‡ 63/104 (60.6) 23/31 (74.2) 11/17 (6.5)
Ejection fraction
50% 118/208 (58.7) 50/70 (71.4) 64/75 (85.3)
,50% 130/216 (60.2) 21/37 (56.8) 46/65 (70.8)
Angiographic findings
LMCA 74/95 (77.9) N/A N/A
3-vessel disease 169/317 (53.3) N/A 27/36 (75.0)
2-vessel disease 5/12 (41.7) 0/1 (0.0) 82/102 (80.4)
1-vessel disease N/A 71/106 (67.0) 1/2 (50.0)
Age (yr)
<60 110/186 (59.1) 41/60 (68.3) 47/66 (71.2)
60–69 94/169 (55.6) 27/41 (65.9) 34/42 (81.0)
70–79 35/51 (68.6) 3/5 (60.0) 29/31 (93.6)
$80 9/18 (50.0) 0/1 (0.0) 0/1 (0.0)
Gender
Male 175/300 (58.3) 37/60 (61.7) 76/94 (80.9)
Female 73/124 (58.9) 34/47 (72.3) 34/46 (73.9)
Ethnicity
White 141/238 (59.2) 42/57 (73.7) 60/73 (82.2)
African-American 20/44 (45.5) 5/10 (50.0) 15/24 (62.5)
Latino 53/83 (63.0) 19/28 (67.9) 22/27 (81.5)
Asian/other 34/59 (57.6) 5/12 (41.7) 13/16 (81.3)
Angiography hospital
Private 1 32/57 (56.1) 11/15 (73.3) 29/33 (87.9)
Private 2 50/80 (62.5) 13/15 (87.7) 19/22 (86.4)
Public 1 3/13 (23.1) 0/5 (0.0) 4/8 (50.0)
Public 2 45/83 (54.0) 16/26 (61.5) 20/25 (80)
Public 3 69/107 (64.5) 22/28 (78.6) 16/22 (72.7)
Public 4 49/84 (58.3) 9/18 (50.0) 22/30 (73.3)
Private combined 82/137 (59.9) 26/30 (86.7) 48/55 (87.3)
Public combined 166/287 (57.8) 47/77 (61.0) 62/85 (72.9)
*Numbers may not add up to 100% due to rounding; boldface 5 referrent category. †At time of coronary angiography.
‡Within 21 days of an acute myocardial infarction. N/A 5 not applicable; other abbreviations as in Tables 1 and 2.
895JACC Vol. 29, No. 5 LAOURI ET AL.
April 1997:891–7 UNDERUSE OF REVASCULARIZATION PROCEDURES
More research is needed to understand and correct these
apparent inequities, which may reflect real but unmeasured
differences in patient preferences, bias in physician judgment
or cultural barriers to physician–patient communication.
We did not observe differences in the receipt of necessary
CABG or PTCA between men and women. The absence of
detectable gender differences is consistent with results of
previous research by Tobin et al. (18), Maynard et al. (19) and
Krumholtz et al. (20) showing that the gender differences
commonly observed in studies of noninvasive cardiac proce-
dures were not observed once the coronary anatomy was
known, and revascularization rates did not differ between men
and women.
For the 85% of Americans with health insurance and their
employers, health care costs are of paramount concern (21).
As cost-containment pressures escalate, it is important that
safeguards be established to promote the provision of highly
beneficial care. The present study shows that even in settings
where most patients are insured and relatively well off, useful
procedures may not be provided. The methods described
herein represent one approach to the measurement and pre-
vention of underuse of health care services. If criteria for
necessity of revascularization were incorporated into standard
teaching and placed on hospital computers, patients needing
revascularization would be identified more readily. Clinicians
could be supported and encouraged to offer necessary proce-
dures to their patients or, alternatively, to provide explicit
clinical justification for not doing so in the medical record. In
this way physicians and hospitals could monitor their own
practice, and outside agencies could assure the public that
cost-cutting measures were not a threat to health.
Study limitations. The major limitations of this study in-
clude the manner of patient selection and limited generaliz-
ability to other procedures and geographic regions. Because
the sample was drawn from patients who had already under-
gone coronary angiography, underuse of CABG and PTCA
may be higher among persons who encounter difficulties
accessing the health care system or obtaining necessary pre-
liminary diagnostic tests. One might expect such difficulties to
be most pronounced for Medicaid patients and for uninsured
patients using the public hospital system. Evidence for this
hypothesis is provided in a related study that showed lower use
of necessary coronary angiography in three public hospitals
compared with a private university hospital (22). In contrast,
the results of the current study may overestimate the extent of
underuse of CABG and PTCA for Los Angeles County as a
whole. Examination of a larger and more diverse sample of
nonpublic hospitals might have revealed a lower overall level
of underuse. Furthermore, although nonclinical factors, such
as organizational characteristics of the hospitals, and the
physicians’ training and specialty, may be important for under-
standing underuse as a function of organizational decision
making, such information was not collected in this study. A
larger number of hospitals would have allowed for a hospital
level analysis of how decisions about revascularization are
made for clinically homogenous patient populations.
Table 5. Adjusted Associations Between Patient Clinical and Demographic Characteristics and
Hospital System Where Coronary Angiography Was Performed With Receipt of Necessary Procedure
CABG Necessary:
Receipt of CABG
[OR (95% CI)]
PTCA Necessary:
Receipt of PTCA
[OR (95% CI)]
CABG/PTCA Necessary:
Receipt of CABG/PTCA
[OR (95% CI)]
Clinical presentation*
CCS class III/IV chronic stable angina 0.86 (0.45, 1.64) — —
Unstable angina 1.03 (0.58, 1.83) 5.75 (1.77, 18.72)† 2.01 (0.71, 5.69)
Post-MI 1.27 (0.69, 2.35) 7.41 (1.75, 31.26)‡ 1.03 (0.24, 4.45)
Ejection fraction§
$50% 0.81 (0.53, 1.24) 4.93 (1.56, 15.57)† 3.25 (1.27, 8.31)‡
Angiographic findings\
LMCA 3.84 (2.13, 0.92)¶ — —
Age (yr)#
60–69 0.74 (0.46, 1.18) 0.66 (0.25, 1.78) 1.72 (0.61, 4.88)
70–79 1.14 (0.52, 2.48) 0.09 (0.01, 1.19) 3.40 (0.77, 14.95)
$80 0.4 (0.13, 1.37) — —
Female gender** 1.08 (0.67, 1.73) 0.96 (0.20, 1.33) 0.62 (0.24, 1.61)
Ethnicity††
African-American 0.49 (0.23, 0.99)‡ 0.20 (0.06, 0.72)‡ 0.59 (0.19, 1.84)
Latino 1.41 (0.78, 2.54) 0.62 (0.19, 2.00) 0.95 (0.33, 2.75)
Asian/other 0.97 (0.50, 1.88) — —
Angiography hospital‡‡
Public 0.96 (0.56, 1.67) 0.10 (0.02, 0.44)† 0.44 (0.15, 1.32)
*Mild angina is the referrent category. †p , 0.005. ‡p , 0.05. §Left ventricular ejection fraction ,50% is the
referrent category. \Three-vessel disease is the referrent category. ¶p , 0.0005. #Age .60 years is the referrent category.
**Male is the referrent category. ††White is the referrent category for CABG model; Asian/other was combined with
white in the PTCA and CABG/PTCA models. ‡‡Private hospital is the referrent category. CI 5 confidence interval;
OR 5 odds ratio; other abbreviations as in Tables 1 and 2.
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Conclusions. In recent years, a large portion of health
services research has been devoted to cost containment and the
elimination of overuse of medical services. The results of the
present study demonstrate the feasibility of a method for
identifying and measuring underuse of medical services, as well
as a clear demonstration that underuse occurs. Given this
knowledge, together with the well documented problems in
access to care experienced by large groups of the population,
further investigation of underuse of medical care is needed to
identify vulnerable patients groups and types of care most
susceptible to underuse. As we reform our health care system
and strive to improve access and quality of care while containing
costs, it is important to bear in mind the health and economic
implications of underuse and to build in safeguards against both
inappropriate overuse and underuse of medical care.
References
1. Ford E, Cooper R, Castaner A, Simmons B, Mar M. Coronary arteriography
and coronary bypass surgery in whites and other racial groups relative to
hospital-based incidence rates for coronary artery disease: findings from
NHDS. Am J Public Health 1989;79:437–40.
2. Goldberg KC, Hartz AJ, Jacobsen SJ, Krakauer H, Rimm AA. Racial and
community factors influencing coronary artery bypass graft surgery rates for
all 1986 Medicare patients. JAMA 1992;267:1473–7.
3. Hadley J, Steinberg EP, Feder J. Uninsured and privately insured patients,
condition on admission, resource use and outcome. JAMA 1991;265:374–9.
4. Hannan E, Kilburn H, O’Donnell J, Lukacik G, Shields E. Interracial access
to selected cardiac procedures for patients hospitalized with coronary artery
disease in New York State. Med Care 1991;29:430–441.
5. Oberman A, Cutter G. Issues in the national history and treatment of
coronary heart disease in black populations: surgical treatment. Am Heart J
1984;108:688–94.
6. Valdez RB, Dallek G. Does the Health Care System Serve Black and Latino
Communities in Los Angeles County? An Analysis of Hospital Use in 1987.
Claremont (CA): The Tomas Rivera Center, 1991.
7. Wenneker MB, Epstein AM. Racial inequalities in the use of procedures for
patients with ischemic heart disease in Massachusetts. JAMA 1989;261:
253–7.
8. Leape LL, Hilborne LH, Kahan JP, et al. Coronary Artery Bypass Graft
Surgery: A Literature Review and Ratings of Appropriateness and Necessity,
1991: RAND, JRA-02; Santa Monica (CA): RAND Corporation, 1991.
9. Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH.
Coronary Percutaneous Transluminal Coronary Angioplasty: A Literature
Review and Ratings of Appropriateness and Necessity, 1991: RAND,
JRA-01; Santa Monica (CA): RAND Corporation, 1991.
10. Kahan J, Bernstein SJ, Leape LL, et al. Measuring the necessity of medical
procedures. Med Care 1994;32:357–65.
11. Lurie N, Ward NB, Shapiro MF, Brook RH, Termination from medical—
does it affect health? N Engl J Med 1984;311:480–4.
12. California Legislative Assembly. AB799, S2012. 1982.
13. Parsonnet V, Dean D, Bernstein A. A method of uniform stratification of
risk for evaluating the results of surgery in acquired adult heart disease.
Circulation 1989;79 Suppl I:I-3–12.
14. Kravitz RL, Laouri M, Hilborne LH, Sherman CT, Guzy P, Brook RH.
Validity of criteria used for detecting underuse of coronary revasculariza-
tion. JAMA 1995;274:632–8.
15. Winslow CM, Kosecoff JB, Chassin M, Kanouse DE, Brook RH. The
appropriateness of performing artery bypass surgery in New York State.
JAMA 1988;260:505–9.
16. Leape LL, Hilborne LH, Park RE, et al. The appropriateness of use of
coronary artery bypass surgery. JAMA 1993;269:753–60.
17. Hilborne LH, Leape LL, Bernstein SJ, et al. The appropriateness of use of
percutaneous transluminal coronary angioplasty in New York State. JAMA
1993;269:761–5.
18. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering
coronary bypass surgery. Ann Intern Med 1987;107:19–25.
19. Maynard C, Litwin PE, Martin JS, Weaver D. Gender differences in the
treatment and outcome of acute myocardial infarction. Arch Intern Med
1992;152:972–6.
20. Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients
for coronary angiography and coronary revascularization early after myocar-
dial infarction: is there evidence for a gender bias? Ann Intern Med
1991;116:785–90.
21. Blendon RJ, Marttila J, Benson JM, Shelter MC, Connolly FJ, Kiley T. The
beliefs and values shaping today’s health reform debate. Health Aff 1994;
13:274–84.
22. Laouri M, Kravitz RL, Bernstein SJ, et al. Underuse of coronary angiogra-
phy: application of a clinical method. Int J Quality Health Care. In press.
897JACC Vol. 29, No. 5 LAOURI ET AL.
April 1997:891–7 UNDERUSE OF REVASCULARIZATION PROCEDURES
